» Articles » PMID: 37772308

Outpatient Motor Retraining for Functional Movement Disorder: Predictors of a Favorable Short-Term Response

Overview
Publisher Wiley
Specialty Neurology
Date 2023 Sep 29
PMID 37772308
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Treating functional movement disorder (FMD) with motor retraining is effective but resource intensive.

Objectives: Identify patient, disease, and program variables associated with favorable treatment outcomes.

Methods: Retrospective review of the 1 week intensive outpatient FMD program at Mayo Clinic in Minnesota from February 2019 to August 2021. Outcomes included patient-reported measures (Canadian Occupational Performance Measure-Performance and Satisfaction subscales [COPM-P and COPM-S, range 0-10] and Global Rating of Change [GROC, -7 to +7]) and a retrospective investigator-rated scale (0-3, worse/not improved to significantly improved/resolved). Linear regression models identified variables predicting favorable outcomes.

Results: Participants (n = 201, 74% female, mean age = 46) had median FMD duration of 24 months. The commonest FMD subtypes were gait disorder (65%), tremor (41%) and weakness (17%); 53% had ≥2 subtypes. Most patients (88%) completed a therapeutic screening process before program entry. Patient-reported outcomes at the end of the week improved substantially (COPM-P average change 3.8 ± 1.9; GROC post-program average 5.5 ± 1.7). Available investigator-rated outcomes from short-term follow-up were also positive (102/122 [84%] moderately to significantly improved/resolved). Factors predicting greater improvement in COPM-P were completing therapeutic screening, higher number of non-motor symptoms, shorter FMD duration, earlier program entry, lower baseline COPM scores, and (among screened patients) higher GROC between therapeutic screening and program start.

Conclusion: Patients with diverse FMD subtypes improved substantially over a 1 week period. Utilization of therapeutic screening and greater improvement between therapeutic screening and program start were novel predictors of favorable outcomes. Non-motor symptoms did not preclude positive responses, although patients with predominant non-motor burden were excluded.

Citing Articles

Biomarkers and Rehabilitation for Functional Neurological Disorder.

Mark V J Pers Med. 2024; 14(9).

PMID: 39338202 PMC: 11433361. DOI: 10.3390/jpm14090948.

References
1.
Nielsen G, Stone J, Matthews A, Brown M, Sparkes C, Farmer R . Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. 2014; 86(10):1113-9. PMC: 4602268. DOI: 10.1136/jnnp-2014-309255. View

2.
Jacob A, Kaelin D, Roach A, Ziegler C, LaFaver K . Motor Retraining (MoRe) for Functional Movement Disorders: Outcomes From a 1-Week Multidisciplinary Rehabilitation Program. PM R. 2018; 10(11):1164-1172. DOI: 10.1016/j.pmrj.2018.05.011. View

3.
Nicholson T, Carson A, Edwards M, Goldstein L, Hallett M, Mildon B . Outcome Measures for Functional Neurological Disorder: A Review of the Theoretical Complexities. J Neuropsychiatry Clin Neurosci. 2019; 32(1):33-42. DOI: 10.1176/appi.neuropsych.19060128. View

4.
Gelauff J, Stone J, Edwards M, Carson A . The prognosis of functional (psychogenic) motor symptoms: a systematic review. J Neurol Neurosurg Psychiatry. 2013; 85(2):220-6. DOI: 10.1136/jnnp-2013-305321. View

5.
Law M, Polatajko H, Pollock N, McColl M, Carswell A, Baptiste S . Pilot testing of the Canadian Occupational Performance Measure: clinical and measurement issues. Can J Occup Ther. 1994; 61(4):191-7. DOI: 10.1177/000841749406100403. View